- Home
- DSY vs DTIL Comparison
DSY vs DTIL Comparison
Compare DSY & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- DTIL
- Stock Information
- Founded
- DSY 2020
- DTIL 2006
- Country
- DSY China
- DTIL United States
- Employees
- DSY N/A
- DTIL N/A
- Industry
- DSY
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- DSY
- DTIL Health Care
- Exchange
- DSY Nasdaq
- DTIL Nasdaq
- Market Cap
- DSY 58.8M
- DTIL 51.6M
- IPO Year
- DSY N/A
- DTIL 2019
- Fundamental
- Price
- DSY $1.25
- DTIL $4.83
- Analyst Decision
- DSY
- DTIL Strong Buy
- Analyst Count
- DSY 0
- DTIL 2
- Target Price
- DSY N/A
- DTIL $47.00
- AVG Volume (30 Days)
- DSY 45.4K
- DTIL 74.8K
- Earning Date
- DSY 02-10-2025
- DTIL 05-15-2025
- Dividend Yield
- DSY N/A
- DTIL N/A
- EPS Growth
- DSY 120.37
- DTIL N/A
- EPS
- DSY 0.01
- DTIL N/A
- Revenue
- DSY $7,323,356.00
- DTIL $51,141,000.00
- Revenue This Year
- DSY N/A
- DTIL N/A
- Revenue Next Year
- DSY N/A
- DTIL $30.20
- P/E Ratio
- DSY $101.45
- DTIL N/A
- Revenue Growth
- DSY 16.37
- DTIL N/A
- 52 Week Low
- DSY $0.75
- DTIL $3.61
- 52 Week High
- DSY $6.98
- DTIL $13.32
- Technical
- Relative Strength Index (RSI)
- DSY 38.53
- DTIL 46.95
- Support Level
- DSY $1.21
- DTIL $4.51
- Resistance Level
- DSY $1.51
- DTIL $5.10
- Average True Range (ATR)
- DSY 0.09
- DTIL 0.27
- MACD
- DSY -0.03
- DTIL -0.00
- Stochastic Oscillator
- DSY 0.02
- DTIL 40.00
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.